OIG - Office of Inspector General
06/09/2026 | Press release | Distributed by Public on 06/09/2026 07:02
AO 21-19
Advisory Opinion 21-19
Status Terminated Posted December 6, 2021 Last updated June 9, 2026Regarding Requestor's provision of free eye drops that mitigate side effects for patients using one of its products.
Advisory Opinion 21-19
PDF, 256.4 KB
Updates
-
June 9, 2026
See Advisory Opinion 26-13 which reflects the Current Arrangement.
Termination of Advisory Opinion 21-19PDF, 306.5 KB
OIG - Office of Inspector General published this content on June 09, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on June 09, 2026 at 13:02 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]